麦克森公司
关于 McKesson
McKesson engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. The North American Pharmaceutical segment focuses on distribution of branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs to customers in U.S. and Canada. The Oncology and Multispecialty segment includes provision of solutions that includes specialty drug distribution, group purchasing organizations, infusion services, direct to patient pharmacy capabilities, InspiroGene cell and gene therapy services, technology solutions, practice consulting services, and vaccine distribution. The RxTS segment focuses on solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The company was founded by John McKesson and Charles Olcott in 1833 and为生物医药企业，从事药品和治疗方案的研发与商业化。 1833年成立。总部位于Irving, TX。
- 成立时间
- 1833
- 首席执行官
- Dr. Brian S. Tyler,PhD
- 员工人数
- 43,000
- 总部地址
- Irving, Texas, United States of America
- 财年结束日
- 03-31
- 官方网站
- mckesson.com
公司概况
- 交易所
- US
- 股票代码
- MCK
- 市值排名
- #209
- 上市日期
- 1970-01-01
- 市值
- 117.15B
- 流通市值
- 116.96B
- 总股数
- 116.59M
- 流通股数
- 116.40M
行业与主题板块
报价时间 2026-10-16 20:02:26 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
麦克森公司 讨论区 0 条评论